Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01518413
Title Dose Escalation Study of Sorafenib and Irinotecan Combination Therapy in Pediatric Patients With Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Children's Research Institute
Indications

rhabdomyosarcoma

neuroblastoma

osteosarcoma

Ewing sarcoma of bone

extraosseous Ewing sarcoma

brain cancer

sarcoma

Advanced Solid Tumor

Therapies

Irinotecan + Sorafenib

Age Groups: adult | child
Covered Countries USA

Facility Status City State Zip Country Details
Children's National Medical Center Washington District of Columbia 20010 United States Details
National Cancer Institute Bethesda Maryland 20892 United States Details
Children's Hospital Boston/Dana-Farber Cancer Institute Boston Massachusetts 02215 United States Details
The Children's Hospital of Philadelphia Philadelphia Pennsylvania 19104 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field